Anavex Life Sciences Corp (AVXL) financials · $247.4M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Anavex Life Sciences Corp (AVXL) $247.4M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$51.4M | -$52.9M |
| Net Income | -$46.4M | -$43.0M |
| EPS (Diluted) | -$0.54 | -$0.52 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $103.8M | $135.6M |
| Cash & Equivalents | $102.6M | $132.2M |
| Total Liabilities | $8.95M | $15.3M |
| Shareholders' Equity | $94.9M | $120.3M |
| Retained Earnings | -$382.4M | -$336.1M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$39.0M | -$30.8M |
| Financing Cash Flow | $9.43M | $12.0M |
FAQ
What is AVXL P/E and revenue?
Anavex Life Sciences Corp (AVXL) $247.4M cap.
What is AVXL revenue?
AVXL income-statement cache has no revenue figure yet.
Is AVXL profitable?
Anavex Life Sciences Corp last cached net income is -$46.4M (FY2025).
What are AVXL total assets?
Anavex Life Sciences Corp last cached total assets are $103.8M (FY2025).
What is AVXL free cash flow?
No cached cash-flow row for AVXL yet.
Not investment advice. Cached statements, not a live tape.